Horizon Investments, LLC Adaptive Biotechnologies Corp Transaction History

Horizon Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $152,145 - $296,566	23,407 New	23,407 $167,000
Q2 2022 Aug 12, 2022	SELL	$6.4 - $14.73 $238,630 - $549,222	-37,286 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $64,828 - $185,133	6,406 Added 20.74%	37,286 $518,000
Q4 2021 Feb 15, 2022	BUY	$25.17 - $36.85 $47,269 - $69,204	1,878 Added 6.48%	30,880 $866,000
Q3 2021 Nov 15, 2021	BUY	$30.02 - $39.87 $870,640 - $1.16 Million	29,002 New	29,002 $986,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Horizon Investments, LLC with notifications on news.